Jagged1-dependent Notch signaling is dispensable for hematopoietic stem cell self-renewal and differentiation

被引:213
作者
Mancini, SJC
Mantei, N
Dumortier, A
Suter, U
MacDonald, HR
Radtke, F [1 ]
机构
[1] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland
[2] Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, Zurich, Switzerland
关键词
D O I
10.1182/blood-2004-08-3207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Jagged1-mediated Notch signaling has been suggested to be critically involved in hematopoietic stem cell (HSC) self-renewal. Unexpectedly, we report here that inducible Cre-loxP-mediated inactivation of the Jagged1 gene in bone marrow progenitors and/or bone marrow (BM) stromal cells does not impair HSC self-renewal or differentiation in all blood lineages. Mice with simultaneous inactivation of Jagged1 and Notch1 in the BM compartment survived normally following a 5FU-based in vivo challenge. In addition, Notch1-deficient HSCs were able to reconstitute mice with inactivated competitive conditions. In contrast to earlier reports, these data exclude an essential role for Jagged1-mediated Notch signaling during hematopoiesis. Jagged1 in the BM stroma even under (c) 2005 by The American Society of Hematology.
引用
收藏
页码:2340 / 2342
页数:3
相关论文
共 19 条
[1]   Osteoblastic cells regulate the haematopoietic stem cell niche [J].
Calvi, LM ;
Adams, GB ;
Weibrecht, KW ;
Weber, JM ;
Olson, DP ;
Knight, MC ;
Martin, RP ;
Schipani, E ;
Divieti, P ;
Bringhurst, FR ;
Milner, LA ;
Kronenberg, HM ;
Scadden, DT .
NATURE, 2003, 425 (6960) :841-846
[2]   Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics [J].
Carlesso, N ;
Aster, JC ;
Sklar, J ;
Scadden, DT .
BLOOD, 1999, 93 (03) :838-848
[3]   Hematopoietic stem cell quiescence maintained by p21cip1/waf1 [J].
Cheng, T ;
Rodrigues, N ;
Shen, HM ;
Yang, YG ;
Dombkowski, D ;
Sykes, M ;
Scadden, DT .
SCIENCE, 2000, 287 (5459) :1804-1808
[4]   β-catenin is dispensable for hematopoiesis and lymphopoiesis [J].
Cobas, M ;
Wilson, A ;
Ernst, B ;
Mancini, JC ;
MacDonald, HR ;
Kemler, R ;
Radtke, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (02) :221-229
[5]  
Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO
[6]  
2-C
[7]   The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells [J].
Karanu, FN ;
Murdoch, B ;
Gallacher, L ;
Wu, DM ;
Koremoto, M ;
Sakano, S ;
Bhatia, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) :1365-1372
[8]   Differential response of primitive human CD34- and CD34+ hematopoietic cells to the Notch ligand Jagged-1 [J].
Karanu, FN ;
Yuefei, L ;
Gallacher, L ;
Sakano, S ;
Bhatia, M .
LEUKEMIA, 2003, 17 (07) :1366-1374
[9]   Biology of hematopoietic stem cells and progenitors: Implications for clinical application [J].
Kondo, M ;
Wagers, AJ ;
Manz, MG ;
Prohaska, SS ;
Scherer, DC ;
Beilhack, GE ;
Shizuru, JA ;
Weissman, IL .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :759-806
[10]   INDUCIBLE GENE TARGETING IN MICE [J].
KUHN, R ;
SCHWENK, F ;
AGUET, M ;
RAJEWSKY, K .
SCIENCE, 1995, 269 (5229) :1427-1429